1989 LONdON, ENGLAND Research TRIAL
- Dr. FRANCO SALOMON and others
"a six-month double-blind, placebo-controlled research trial
on 24 adults With deficinecy levels of human growth hormone"
In 1989, in London, England - Dr. Franco Salomon and his team of associates conducted a six-month research trial. They gave [ synthetic ] Human Growth Hormone ( HGH ) to a group of 24 adults, who each had low levels of Growth Hormone ( GH ). This was similar to the study that Dr. Daniel Rudman completed about one year later.
Over a period of six months, they conducted a Double-Blind, Placebo-Controlled Research Trial in that group of adults who had a deficiency of Growth Hormone ( GH ). According to their report, most of the patients had developed this deficiency in levels of Growth Hormone ( GH ) during adulthood. This was as a result of their having had treatment for tumors in their Pituitary Glands.
Moreover, all of those who participated in this Study were receiving Hormone Replacement Therapy ( HRT ) for either Thyroid Glands, Adrenal Glands or Gonadal Glands.
The researchers then studied the effects of treating these people with measured dosages of [ synthetic ] Human Growth Hormone ( HGH ). They gave the patients a dose of recombinant Human Growth Hormone ( r-HgH ) at 0.07 U per kg of body weight, given under the skin at bedtime.
the Results of their Research TRIAL
Here are the results of their research trial:
The mean plasma concentration of Insulin-Like Growth Factor 1 ( IGF-1 ) increased from 0.41 ( ±0.05 ) to 1.53 ( ±0.16 )
U per liter during the administration of the treatment.
The mean Lean Body Mass increased by over 10%, while the Fat Mass decreased by 7% in the group of adults treated with the Growth Hormone ( GH ). Neither of these measurements changed significantly in the group of patients who were not treated ( placebo group ).
Additionally, the basal Metabolic Rate, in those given the treatment plan, increased significantly. At the same time, the fasting plasma Cholesterol levels of those treated had decreased.
Conclusion of the results of the research trial
Based on the positive results of the treatment plan of administering the [ synthetic ] Human Growth Hormone ( HGH ), the researchers wrote the following in their published report:
"We conclude that growth hormone { GH } has a role in the regulation of body composition in adults, probably through its anabolic and lipolytic actions."